William P. Quinn's most recent trade in Bolt Biotherapeutics Inc was a trade of 20,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 28, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2026 | 20,000 | 20,000 | - | - | Employee Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Purchase of securities on an exchange or from another person at price $ 4.61 per share. | 28 Jan 2026 | 125 | 2,313 | - | 4.6 | 576 | Common Stock |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 34,999 | 34,999 | - | - | Employee Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 34,999 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 21,999 | 21,999 | - | - | Employee Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 21,999 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 12,499 | 12,499 | - | - | Employee Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 12,499 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 11,749 | 11,749 | - | - | Employee Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 11,749 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 10,499 | 10,499 | - | - | Employee Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 10,499 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 7,614 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 7,614 | 7,614 | - | - | Employee Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 5,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 5,000 | 5,000 | - | - | Employee Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 3,927 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 3,927 | 3,927 | - | - | Employee Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2025 | 40,000 | 42,188 | - | 0 | Common Stock | |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Purchase of securities on an exchange or from another person at price $ 5.50 per share. | 24 Oct 2025 | 125 | 2,188 | - | 5.5 | 687 | Common Stock |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 700,000 | 700,000 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Purchase of securities on an exchange or from another person at price $ 0.50 per share. | 01 May 2025 | 2,500 | 41,272 | - | 0.5 | 1,241 | Common Stock |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Purchase of securities on an exchange or from another person at price $ 0.64 per share. | 01 May 2025 | 2,500 | 38,772 | - | 0.6 | 1,594 | Common Stock |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2024 | 440,000 | 440,000 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 235,000 | 235,000 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | P. William Quinn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.95 per share. | 12 Dec 2023 | 7,500 | 36,272 | - | 1.0 | 7,125 | Common Stock |
| Bolt Biotherapeutics Inc | P. William Quinn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.78 per share. | 12 Dec 2023 | 2,500 | 28,772 | - | 0.8 | 1,955 | Common Stock |
| Bolt Biotherapeutics Inc | P. Quinn William | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.18 per share. | 12 Dec 2023 | 1,829 | 26,272 | - | 1.2 | 2,161 | Common Stock |
| Bolt Biotherapeutics Inc | William P. Quinn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.64 per share. | 31 Dec 2022 | 2,500 | 22,654 | - | 1.6 | 4,101 | Common Stock |
| Bolt Biotherapeutics Inc | William P. Quinn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.18 per share. | 31 Dec 2022 | 1,789 | 24,443 | - | 1.2 | 2,114 | Common Stock |
| Bolt Biotherapeutics Inc | William P. Quinn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 210,000 | 210,000 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.72 per share. | 08 Dec 2021 | 5,000 | 20,154 | - | 4.7 | 23,575 | Common Stock |
| Bolt Biotherapeutics Inc | William P. Quinn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 16.65 per share. | 08 Dec 2021 | 1,221 | 15,119 | - | 16.7 | 20,330 | Common Stock |
| Bolt Biotherapeutics Inc | William P. Quinn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.63 per share. | 08 Dec 2021 | 35 | 15,154 | - | 4.6 | 162 | Common Stock |